France En 2060, la santé coûterait 11,5% du PIB
04/01/2014Digital health’s top deal-doers: These funds invested in the most companies last year
04/01/2014Trial data transparency under fire from UK parliamentary committee
An influential group of MPs forming Parliament’s Public Accounts Committee has strongly criticised pharmaceutical companies and UK health regulatory bodies over the extent and transparency of practices for sharing information from clinical trials….
See on www.pharmaphorum.com
